Shabi Parvez

408 total citations
16 papers, 298 citations indexed

About

Shabi Parvez is a scholar working on Pharmaceutical Science, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Shabi Parvez has authored 16 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmaceutical Science, 5 papers in Public Health, Environmental and Occupational Health and 4 papers in Immunology. Recurrent topics in Shabi Parvez's work include Research on Leishmaniasis Studies (5 papers), Nanoparticle-Based Drug Delivery (3 papers) and Advanced Drug Delivery Systems (3 papers). Shabi Parvez is often cited by papers focused on Research on Leishmaniasis Studies (5 papers), Nanoparticle-Based Drug Delivery (3 papers) and Advanced Drug Delivery Systems (3 papers). Shabi Parvez collaborates with scholars based in India, United States and Italy. Shabi Parvez's co-authors include Shyam Lal Mudavath, Om Prakash Singh, Ganesh Yadagiri, Aakriti Singh, Anurag Verma, Shyam Sundar, Mallikarjuna Rao Gedda, Vikas Jain, Shyam Sundar and Kanika Arora and has published in prestigious journals such as Scientific Reports, Chemical Engineering Journal and Life Sciences.

In The Last Decade

Shabi Parvez

15 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shabi Parvez India 10 104 84 81 56 35 16 298
Rui M. Lopes Portugal 13 128 1.2× 86 1.0× 149 1.8× 74 1.3× 43 1.2× 16 437
Ali Rezaei Mokarram Iran 9 110 1.1× 48 0.6× 79 1.0× 54 1.0× 22 0.6× 15 307
María Julia Altube Argentina 11 110 1.1× 50 0.6× 92 1.1× 32 0.6× 39 1.1× 16 327
Carol Yousry Egypt 13 87 0.8× 58 0.7× 208 2.6× 77 1.4× 28 0.8× 20 411
Sixiang Sai China 8 80 0.8× 46 0.5× 106 1.3× 43 0.8× 25 0.7× 14 278
Ana Paula dos Santos Matos Brazil 12 61 0.6× 77 0.9× 64 0.8× 74 1.3× 91 2.6× 34 364
Ganesh Yadagiri India 12 106 1.0× 136 1.6× 87 1.1× 37 0.7× 11 0.3× 27 368
Shaswat Kansal India 9 46 0.4× 70 0.8× 211 2.6× 56 1.0× 44 1.3× 11 375
Rita Spagnolo Italy 9 81 0.8× 39 0.5× 122 1.5× 70 1.3× 57 1.6× 13 323
Akhil Suresh India 10 103 1.0× 155 1.8× 82 1.0× 97 1.7× 74 2.1× 20 532

Countries citing papers authored by Shabi Parvez

Since Specialization
Citations

This map shows the geographic impact of Shabi Parvez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shabi Parvez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shabi Parvez more than expected).

Fields of papers citing papers by Shabi Parvez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shabi Parvez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shabi Parvez. The network helps show where Shabi Parvez may publish in the future.

Co-authorship network of co-authors of Shabi Parvez

This figure shows the co-authorship network connecting the top 25 collaborators of Shabi Parvez. A scholar is included among the top collaborators of Shabi Parvez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shabi Parvez. Shabi Parvez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Parvez, Shabi, et al.. (2025). Influenza Virus: Global Health Impact, Strategies, Challenges, Role of Nanotechnolgy in Influenza Vaccine Development. Vaccines. 13(9). 890–890. 1 indexed citations
3.
Kumar, Arvind, Vijay P. Singh, Arun Kumar Mishra, et al.. (2024). Synthesis, characterization and computational studies of some new vanillin derivatives for cosmetic purpose. Journal of Molecular Structure. 1327. 141127–141127. 1 indexed citations
4.
Parvez, Shabi, et al.. (2023). Folate receptor targeted NIR cleavable liposomal delivery system augment penetration and therapeutic efficacy in breast cancer. Biochimica et Biophysica Acta (BBA) - General Subjects. 1867(9). 130396–130396. 20 indexed citations
5.
Singh, Aakriti, et al.. (2023). Carboxymethyl Tamarind seed polysaccharide nanoparticles as a potent mucomimetic and biocompatible oral nanocarrier. Colloids and Surfaces A Physicochemical and Engineering Aspects. 682. 132889–132889. 6 indexed citations
6.
Parvez, Shabi, et al.. (2022). Transport mechanism of hydroxy-propyl-beta-cyclodextrin modified solid lipid nanoparticles across human epithelial cells for the oral absorption of antileishmanial drugs. Biochimica et Biophysica Acta (BBA) - General Subjects. 1866(8). 130157–130157. 13 indexed citations
7.
Parvez, Shabi, et al.. (2022). Fabrication, physicochemical characterization and In vitro anticancer activity of nerolidol encapsulated solid lipid nanoparticles in human colorectal cell line. Colloids and Surfaces B Biointerfaces. 215. 112520–112520. 20 indexed citations
8.
Parvez, Shabi, et al.. (2022). Organ-restricted delivery through stimuli-responsive nanocarriers for lung cancer therapy. Life Sciences. 310. 121133–121133. 25 indexed citations
9.
Parvez, Shabi, et al.. (2022). Effervescent based nano-gas carrier enhanced the bioavailability of poorly aqueous soluble drug: A comprehensive mechanistic understanding. Journal of Drug Delivery Science and Technology. 69. 103167–103167. 12 indexed citations
10.
Parvez, Shabi, et al.. (2022). Nanoformulation mediated silencing of P-gp efflux protein for the efficient oral delivery of anti-leishmanial drugs. Journal of Drug Delivery Science and Technology. 78. 103959–103959. 2 indexed citations
11.
Parvez, Shabi, Ganesh Yadagiri, Kanika Arora, et al.. (2021). Coalition of Biological Agent (Melatonin) With Chemotherapeutic Agent (Amphotericin B) for Combating Visceral Leishmaniasis via Oral Administration of Modified Solid Lipid Nanoparticles. ACS Biomaterials Science & Engineering. 9(6). 2902–2910. 15 indexed citations
12.
Parvez, Shabi, Ganesh Yadagiri, Aakriti Singh, et al.. (2020). Improvising anti-leishmanial activity of amphotericin B and paromomycin using co-delivery in d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) tailored nano-lipid carrier system. Chemistry and Physics of Lipids. 231. 104946–104946. 15 indexed citations
13.
Parvez, Shabi, Ganesh Yadagiri, Om Prakash Singh, et al.. (2020). Recuperating Biopharmaceutical Aspects of Amphotericin B and Paromomycin Using a Chitosan Functionalized Nanocarrier via Oral Route for Enhanced Anti-leishmanial Activity. Frontiers in Cellular and Infection Microbiology. 10. 570573–570573. 22 indexed citations
14.
Parvez, Shabi, Ganesh Yadagiri, Mallikarjuna Rao Gedda, et al.. (2020). Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis. Scientific Reports. 10(1). 12243–12243. 96 indexed citations
15.
Singh, Aakriti, Ganesh Yadagiri, Shabi Parvez, et al.. (2020). Formulation, characterization and in vitro anti-leishmanial evaluation of amphotericin B loaded solid lipid nanoparticles coated with vitamin B12-stearic acid conjugate. Materials Science and Engineering C. 117. 111279–111279. 41 indexed citations
16.
Singh, Aakriti, Sandeep Sharma, Ganesh Yadagiri, et al.. (2020). Sensible graphene oxide differentiates macrophages and Leishmania: a bio-nano interplay in attenuating intracellular parasite. RSC Advances. 10(46). 27502–27511. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rui M. Lopes Breakdown of academic impact, for papers by Ali Rezaei Mokarram Breakdown of academic impact, for papers by María Julia Altube Breakdown of academic impact, for papers by Carol Yousry Breakdown of academic impact, for papers by Sixiang Sai Breakdown of academic impact, for papers by Ana Paula dos Santos Matos Breakdown of academic impact, for papers by Ganesh Yadagiri Breakdown of academic impact, for papers by Shaswat Kansal Breakdown of academic impact, for papers by Rita Spagnolo Breakdown of academic impact, for papers by Akhil Suresh
Rankless by CCL
2026